Danny Lascano MD
Colon & Rectal Surgery, Hepatobiliary Surgery, Surgical Oncology (Other than Breast)
CGSO Fellow at St. John Cancer Institue
Join to View Full Profile
2121 Santa Monica BlvdSanta Monica, CA 90404
Phone+1 310-315-6125
Fax+1 310-582-7163
Dr. Lascano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Danny Lascano is a general surgeon in Santa Monica, CA and is affiliated with Providence Saint John's Health Center. He graduated from Columbia University College of Physicians and Surgeons. He completed general surgery residency at WCMC- New York Medical College. He specializes in general surgery and surgical oncology.
Education & Training
Westchester Medical CenterResidency, Surgery, 2016 - 2023
Columbia University Vagelos College of Physicians and SurgeonsClass of 2016
Certifications & Licensure
CA State Medical License 2019 - 2027
American Board of Surgery Surgery
Awards, Honors, & Recognition
- Ferdinand C. Valentine Resident Essay Contest Winner New York Academy of Medicine, 2015
- Ferdinand C. Valentine Medical Student Research Grant New York Academy of Medicine, 2015
- NIH T35 Grant NIDDK-NIH, 2014
Clinical Trials
- Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer Start of enrollment: 2014 Apr 09
Publications & Presentations
PubMed
- Metastatic Melanoma Outcomes and the Evolving Role of Surgery in the Immunotherapy Era.Hilary R Keller, Douglas A Hanes, Jillian K McCabe, Danny Lascano, Paul Shin
JAMA Surgery. 2025-07-23 - 1 citationsOptimizing the Postoperative Management of Children Undergoing Resection of High-Risk Abdominal Neuroblastoma.William G Lee, Danny Lascano, Samiza B Palmer, Stephanie Y Chen, Shale J Mack
The American Surgeon. 2024-06-01 - 1 citationsAnti-CCL2 antibody combined with etoposide prolongs survival in a minimal residual disease mouse model of neuroblastoma.Danny Lascano, Michael J Zobel, William G Lee, Stephanie Y Chen, Abigail Zamora
Scientific Reports. 2023-11-14
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
